HASSANEIN WALEED H (President & CEO) purchased 3.6% of their position (16.88K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market purchase worth $1.98M — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 8/8/2025ACC: 0000950170-25-105907
DirectorOfficer· President & CEO
Since May 2019
+16.88K
Net shares
Net buyer
$1.98M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
16.88K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+8.40K
Price / share
$118.68
Trade value
$996.91K
% of position
1.8%
8/6/2025
469.36K→477.76K
Common Stock
Indirect
Shares
+6.62K
Price / share
$116.08
Trade value
$768.10K
% of position
1.4%
8/7/2025
477.76K→484.38K
Common Stock
Indirect
Shares
+1.86K
Price / share
$116.85
Trade value
$217.11K
% of position
0.4%
8/7/2025
484.38K→486.23K
Total
Net shares
+16.88K
Net value
$1.98M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/6/2025 | P · Purchase | +8.40K | $118.68 | $996.91K | 1.8% | 469.36K | 477.76K |
| Common Stock Indirect | 8/7/2025 | P · Purchase | +6.62K | $116.08 | $768.10K | 1.4% | 477.76K | 484.38K |
| Common Stock Indirect | 8/7/2025 | P · Purchase | +1.86K | $116.85 | $217.11K | 0.4% | 484.38K | 486.23K |
| Total | +16.88K | $1.98M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned121.42K
Total
121.42K direct121.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 121.42K | Direct |
| Total | 121.42K | 121.42K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported